# Development of novel microbial synthetic consortia for the production of antimicrobial fermentates containing caproate

**Authors:** Maria Florencia Bambace, Ker Sin Ng, Kirsten Wiborg Jensen, Adrien Schneider, Mensure Elvan Gezer, Angeliki Marietou, Aviaja Kristiansen Aarseth, Annika Regnet, Kathrine Gravlund Fønss, Ulrik Kræmer Sundekilde, Clarissa Schwab

PMC · DOI: 10.1007/s00253-026-13718-z · Applied Microbiology and Biotechnology · 2026-02-27

## TL;DR

This study designed a microbial consortium to produce caproate, a natural antimicrobial, which showed strong activity against bacteria, yeast, and mold in food applications.

## Contribution

A novel multi-kingdom microbial consortium was developed to produce caproate-containing fermentates with antimicrobial properties.

## Key findings

- Caproate levels reached 63.9 mM in a 22-day bioprocess with ethanol addition.
- Fermentates inhibited bacteria, yeast, and mold growth, especially at pH 4.5.
- Lactate and caproate acted synergistically in minced meat to enhance antimicrobial activity.

## Abstract

Short- and medium chain carboxylic acids (SCCA/MCCA) are natural antimicrobials produced by fermentation and chain elongation, but currently only a few SCCA/MCCA are used in food-related applications. With the aim to diversify the SCCA/MCCA profile of fermentates for biopreservation, we designed bioprocesses employing bacterial or multi-kingdom consortia to produce caproate-containing fermentates using a targeted cross-feeding strategy. We combined Limosilactobacillus reuteri, Clostridium kluyveri, and Saccharomyces cerevisiae, and quantified substrates utilization and metabolites. The antimicrobial activity of SCCA/MCCA and fermentates was analysed in vitro and in a meat model system. In a first bioprocess, the addition of ethanol (EtOH) initiated caproate formation by the bacterial consortium with levels of 63.9 mM (7.4 g L−1) after 22 days. Next, we run two shorter bioprocesses (12 days) and more caproate (28.9 mM, 3.4 g L−1) was produced if EtOH was regularly added than without EtOH supplementation (21.7 mM, 2.5 g L−1). When S. cerevisiae was included, 37.9 ± 11.4 mM (4.4 g L−1) caproate was formed without EtOH addition. Beyond the intended cross-feeding activity, consortia produced and re-metabolised mannitol and glycerol. Lactate and caproate were the major carboxylic acids in fermentates. Caproate inhibited bacteria, yeast and molds at pH 4.5 and 6.5 in vitro, while lactate and caproate acted synergistically in minced meat. Fermentates conferred antimicrobial activity against indicator microbes mostly at pH 4.5 and to a lesser extent at pH 6.5. In this study we successfully designed a consortium to produce caproate. We provide evidence that caproate-containing fermentates had strong antimicrobial activity, and our results indicate the complexity of metabolic interactions that occurred within consortium members.

• Design of a self-contained bioprocess with multi-kingdom consortium.

• Cross-feeding of bacteria and yeast to produce caproate fermentates.

• Fermentates containing caproate inhibited bacteria, yeast and mold growth.

The online version contains supplementary material available at 10.1007/s00253-026-13718-z.

## Linked entities

- **Chemicals:** caproate (PubChem CID 4398339), ethanol (PubChem CID 702), lactate (PubChem CID 61503), mannitol (PubChem CID 6251), glycerol (PubChem CID 753)
- **Species:** Limosilactobacillus reuteri (taxon 1598), Clostridium kluyveri (taxon 1534), Saccharomyces cerevisiae (taxon 4932)

## Full-text entities

- **Diseases:** DSM 20649 (MESH:D001714)
- **Chemicals:** maltose (MESH:D008320), CA (MESH:C037652), KH2PO4 (-), sodium phosphate (MESH:C018279), 1,3-propanediol (MESH:C041787), Glycerol (MESH:D005990), sugar alcohols (MESH:D013402), Butyrate (MESH:D002087), carbohydrates (MESH:D002241), hexanoyl-CoA (MESH:C044181), acrolein (MESH:D000171), Propionate (MESH:D011422), SYBR Green (MESH:C098022), Mannitol (MESH:D008353), CO2 (MESH:D002245), citrate (MESH:D019343), ATP (MESH:D000255), Fructose (MESH:D005632), cobalamin (MESH:D014805), butyryl-CoA (MESH:C024343), alcohols (MESH:D000438), PB (MESH:D007854), acetate (MESH:D000085), H2SO4 (MESH:C033158), GF (MESH:C053914), Glucose (MESH:D005947), potassium acetate (MESH:D019347), pyruvate (MESH:D019289), Oxygen (MESH:D010100), sugar (MESH:D000073893), formate (MESH:C030544), carboxylic acids (MESH:D002264), potassium phosphate (MESH:C013216), LA (MESH:D019344), lactose (MESH:D007785), 3-HPA (MESH:C047158), carbon (MESH:D002244), G-I (MESH:C001311), agar (MESH:D000362), acetonitrile (MESH:C032159), water (MESH:D014867), D2O (MESH:D017666), acetyl-CoA (MESH:D000105), HCl (MESH:D006851), valerate (MESH:D014631), NaOH (MESH:D012972), 3-HP (MESH:C031601), EtOH (MESH:D000431)
- **Species:** Lactobacillaceae (family) [taxon 33958], Klebsiella oxytoca (species) [taxon 571], Listeria monocytogenes (species) [taxon 1639], Kosakonia cowanii (NIH group 42, species) [taxon 208223], Clostridium acetobutylicum ATCC 824 (strain) [taxon 272562], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606], Clostridioides difficile (species) [taxon 1496], Pichia kluyveri (species) [taxon 36015], Bacillus subtilis subsp. subtilis (subspecies) [taxon 135461], Limosilactobacillus reuteri (species) [taxon 1598], Candida albicans (species) [taxon 5476], Listeria innocua (species) [taxon 1642], Pantoea sp. (species) [taxon 69393], Bacillus subtilis (species) [taxon 1423], Escherichia coli (E. coli, species) [taxon 562], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Clostridium kluyveri (species) [taxon 1534], Clostridium kluyveri DSM 555 (strain) [taxon 431943], Salmonella enterica (species) [taxon 28901], Pantoea ananatis (species) [taxon 553], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Clostridia (class) [taxon 186801], Talaromyces purpureogenus (species) [taxon 1266744]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), ATCC 8527 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), DSM 556 — Homo sapiens (Human), Desmoid fibromatosis, Cancer cell line (CVCL_C7G0), YC-GF — Epinephelus coioides (Orange-spotted grouper), Spontaneously immortalized cell line (CVCL_J030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950656/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950656/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950656/full.md

---
Source: https://tomesphere.com/paper/PMC12950656